High-Sensitivity C-Reactive Protein is a Strong Risk Factor for Death after Acute Ischemic Stroke among Chinese

CNS Neuroscience and Therapeutics

Volumn 18, Issue 3, 2012, Pages 261-266

  Huang, Yue ^a   Jing, Jing ^b   Zhao, Xing Quan ^b   Wang, Chun Xue ^b   Wang, Yi Long ^b   Liu, Gai Fen ^b   Wang, Chun Juan ^b   Liu, Li Ping ^b   Yang, Xiao Meng ^b   Jiao, Yan ^a   Jiao, Yun ^c   Wang, Li Shi ^a   Wang, Yong Jun ^b   Gu, Wei Kuan ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

High sensitivity C reactive protein; Inflammation; Ischemic stroke; Prognosis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GLUCOSE; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLISM; CARDIOVASCULAR RISK; CHINESE; CLINICAL EVALUATION; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; ELECTROCARDIOGRAM; EMBOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; INTRACRANIAL HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PERFORATING ARTERY; PERIPHERAL VASCULAR DISEASE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING; SURVIVAL; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STROKE; SURVIVAL RATE;

EID: 84863229644     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2012.00296.x     Document Type: Article

References (42)

1. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874.
2. Chamorro A. Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis 2004;17(Suppl 3):1-5.
3. Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest 2003;111:1805-1812.
4. Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: A systematic review. Stroke 2009;40:e380-e389.
5. Pola R. Inflammatory markers for ischaemic stroke. Thromb Haemost 2009;101:800-801.
6. Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J 2010;31:2087-2091.
7. Marsik C, Kazemi-Shirazi L, Schickbauer T, Winkler S, Joukhadar C, Wagner OF, Endler G. C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem 2008;54:343-349.
8. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein and all-cause mortality-the copenhagen city heart study. Eur Heart J 2010;31:1624-1632.
9. Cao JJ, Arnold AM, Manolio TA, et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: The cardiovascular health study. Circulation 2007;116:32-38.
10. Currie CJ, Poole CD, Conway P. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-462.
11. Shantikumar S, Grant PJ, Catto AJ, Bamford JM, Carter AM. Elevated C-reactive protein and long-term mortality after ischaemic stroke: Relationship with markers of endothelial cell and platelet activation. Stroke 2009;40:977-979.
12. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke 1999;30:981-985.
13. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke 2001;32:917-924.
14. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001;32:133-138.
15. Arenillas JF, Alvarez-Sabin J, Molina CA, et al. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003;34:2463-2468.
16. Di Napoli M, Godoy DA, Campi V, et al. C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score. Stroke 2011;42:1230-1236.
17. Yan J, Liao JK, Wang D. Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in chinese patients. J Huazhong Univ Sci Technolog Med Sci 2010;30:643-647.
18. Yan J, Hui R, Wang D. Elevated C-reactive protein levels predict worsening prognosis in chinese patients with first-onset stroke. Front Med China 2009;3:30-35.
19. Gao S, Wang YJ, Xu AD, Li YS, Wang DZ. Chinese ischemic stroke subclassification. Front Neurol 2011;2:6. doi:.
20. Spence JD. Nutrition and stroke prevention. Stroke 2006;37:2430-2435.
21. Rizzo M, Corrado E, Coppola G, Muratori I, Novo S. Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: The role of c-reactive protein. J Investig Med 2008;56:32-40.
22. Rothenburg LS, Herrmann N, Swardfager W, et al. The relationship between inflammatory markers and post stroke cognitive impairment. J Geriatr Psychiatry Neurol 2010;23:199-205.
23. Goto S, Ikeda Y, Shimada K, Uchiyama S, Origasa H, Kobayashi H. One-year cardiovascular event rates in japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. Circ J 2011;75:2598-2604.
24. Wang CJ, Wang CX, Zhang L, Wang YL, Wang YJ. Advances in stroke care and research in 2010. Clin Exp Pharmacol Physiol 2011;38:562-569.
25. Makita S, Nakamura M, Satoh K, et al. Serum c-reactive protein levels can be used to predict future ischemic stroke and mortality in japanese men from the general population. Atherosclerosis 2009;204:234-238.
26. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2010;375:132-140.
27. Rallidis LS, Vikelis M, Panagiotakos DB, Rizos I, Zolindaki MG, Kaliva K, Kremastinos DT. Inflammatory markers and in-hospital mortality in acute ischaemic stroke. Atherosclerosis 2006;189:193-197.
28. den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, Koudstaal PJ, Dippel DW. C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death. J Neurol 2009;256:2003-2008.
29. Welsh P, Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc Dis 2009;27:247-253.
30. Christensen H, Boysen G. C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke. Cerebrovasc Dis 2004;18:214-219.
31. Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'bergen stroke study'. BMC Neurol 2009;9:18. doi:.
32. Corso G, Bottacchi E, Brusa A, et al. Is there a prognostic role for C-reactive protein in ischemic stroke? Acta Neurol Scand 2010;122:209-216.
33. Whiteley W, Jackson C, Lewis S, et al. Association of circulating inflammatory markers with recurrent vascular events after stroke: A prospective cohort study. Stroke 2011;42:10-16.
34. Kravitz BA, Corrada MM, Kawas CH. High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: Results from the 90+ study. J Am Geriatr Soc 2009;57:641-646.
35. Anuk T, Assayag EB, Rotstein R, et al. Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurol Scand 2002;106:196-199.
36. Elkind MS, Tai W, Coates K, Paik MC, Sacco RL. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase a2, and outcome after ischemic stroke. Arch Intern Med 2006;166:2073-2080.
37. Song IU, Kim JS, Kim YI, Lee KS, Jeong DS, Chung SW. Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a korean population. Cerebrovasc Dis 2009;28:545-550.
38. Song IU, Kim YD, Kim JS, Lee KS, Chung SW. Can high-sensitivity C-reactive protein and plasma homocysteine levels independently predict the prognosis of patients with functional disability after first-ever ischemic stroke? Eur Neurol 2010;64:304-310.
39. Worthmann H, Tryc AB, Goldbecker A, et al. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome. Cerebrovasc Dis 2010;30:85-92.
40. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002;33:2459-2464.
41. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke 1993;24:35-41.
42. Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006;37:2018-2023.